Core Insights - Intuitive Surgical (ISRG) reported strong preliminary revenue results for Q4 2023, with net sales estimated at least $1.93 billion, reflecting a 17% year-over-year increase [1] - The company anticipates full-year revenues of $7.12 billion for 2023, indicating a 14% year-over-year growth [2] Revenue Performance - Q4 2023 net sales are projected at $1.93 billion, surpassing the Zacks Consensus Estimate of $1.86 billion [1] - Sales from instruments and accessories reached $1.14 billion, marking a 22% year-over-year growth, driven by increased da Vinci procedure volume and higher pricing [1] - Full-year revenues from instruments and accessories were $4.28 billion, up 22%, while systems revenue remained flat at $1.68 billion [2] Procedure Volume and System Placements - Da Vinci procedures grew approximately 21% worldwide in Q4 2023, benefiting from a favorable comparison to the previous year when COVID-19 impacted volumes [2] - The company placed 415 da Vinci systems in Q4 2023, reflecting a 12% year-over-year increase, which is expected to support continued growth in procedure volumes in 2024 [2][3] Market Recovery - The company completed about 2,286,000 surgical procedures with da Vinci systems in 2023, a 22% increase from 2022, attributed to improved market conditions, particularly in general surgery and cancer procedures [3] - COVID-19 disruptions were minimal in the second half of 2023, leading to a recovery in procedure volumes, particularly in China [4] Stock Performance - ISRG shares rose 15.4% from October 1 to December 31, 2023, outperforming the industry growth of 10.1% and the S&P 500's 10.6% increase during the same period [5]

Another healthy day for market indices today is always a welcome sight. We’re operating with little data to this stage in the week, but we won’t turn our nose up at modest bullish sentiment. The Dow was just off session highs, +170 points, +0.45%, while the S&P 500 moved back above 4780: +0.57%. Both are a smidge off all-time highs reached just last week. The Nasdaq outperformed the field, +111 points, +0.75% and riding a four-day winning streak, while the small-cap Russell 2000 took a breather today, -0.24 ...

Key TakeawaysThe S&P 500 gained 0.6% on Wednesday, Jan. 10, 2024, ahead of inflation data and bank earnings later in the week.Intuitive Surgical shares surged after it beat revenue estimates on increased usage of its da Vinci robotic surgical system.Capital One Financial fell after a BMO downgrade on concerns over charge-offs for uncollected debt.The S&P 500 posted a gain of 0.6% on Wednesday ahead of key inflation data and bank earnings due later in the week. The Nasdaq rose 0.8%, while the Dow moved highe ...

Summary of Intuitive Surgical, Inc. Conference Call Company Overview - **Company**: Intuitive Surgical, Inc. (NASDAQ: ISRG) - **Event**: JPMorgan Healthcare Conference Call - **Date**: January 10, 2024 Key Points Industry and Market Dynamics - The company focuses on minimally invasive care and acute interventions, emphasizing the need for advanced technologies to improve healthcare outcomes [2][3] - The total experience on da Vinci platforms has surpassed 14 million procedures, with over 2.2 million procedures performed in the last year [3][4] - The installed base of systems has grown to over 9,100, with significant placements across various platforms [4] Financial Performance - The company reported a 22% growth in procedures for the year, with a projected growth rate of 13% to 16% for 2024 [10][46] - Revenue growth is slower than procedure growth due to a higher mix of risk-sharing arrangements and leasing in the capital portfolio [12][13] - The installed base grew by 14%, indicating increased utilization of systems [11] Challenges and Risks - Environmental uncertainties in China, including regulatory pressures and pricing regulations, have impacted business performance [5] - The rise of GLP-1 medications has led to a deceleration in bariatric surgery growth, which is expected to continue [6][48] - Manufacturing constraints, particularly in the flexible bronchoscopy space, have limited system installations [7][8] Growth Opportunities - The company sees a potential market of approximately 7 million patients annually, with aspirations to grow this to 21 million through innovation [14][15] - The Ion system for flexible bronchoscopy is gaining traction, with significant growth in procedures [16][17] - The company is focused on expanding its platforms and indications, particularly in international markets [39] Technological Advancements - Intuitive Surgical is investing in AI and machine learning to enhance surgical outcomes and operational efficiency [24][26] - The company is developing tools for preoperative planning, intraoperative guidance, and postoperative analytics [28][30] - The integration of telemedicine and teleproctoring capabilities is being explored to enhance surgical support [33] Customer Engagement and Satisfaction - The company measures customer satisfaction through Net Promoter Scores, achieving an 80% score in the U.S. [38] - The focus is on aligning with customer needs and demonstrating the value of their products through data-driven outcomes [61][62] Future Outlook - The company plans to focus on innovation, quality improvement, and optimizing manufacturing processes in 2024 [39][55] - There is an emphasis on understanding the impact of AI and big data on the surgical robotics field over the next decade [64] Additional Insights - The company is cautious about the impact of economic conditions on procedure growth, particularly in relation to patient backlogs and market dynamics in China [47][48] - The competitive landscape is influenced by disease state-level competition, with a focus on delivering better patient outcomes and experiences [60][61] This summary encapsulates the key insights from the conference call, highlighting the company's performance, challenges, growth opportunities, and strategic focus areas for the future.

Intuitive Surgical, Inc. (NASDAQ:ISRG) JPMorgan Healthcare Conference Call January 10, 2024 12:00 PM ET Company Participants Gary Guthart - CEO & Director Brian King - Head, IR Jamie Samath - SVP & CFO Conference Call Participants Robert Marcus - JPMorgan Chase & Co. Robert Marcus Good morning, everyone. Happy to continue day 3 of the JPMorgan Healthcare Conference. I'm Robbie Marcus, the Medtech Analyst. Really pleased to introduce our next session. CEO of Intuitive Surgical, Gary Guthart, will do a quick ...

Shares of Intuitive Surgical Inc. rallied 9.5% Wednesday to lead S&P 500 gainers, after the maker of robotic surgical equipment updated guidance for fourth-quarter sales with some bullish numbers, buoyed by a recovery in China. The stock ISRG, +10.16% was on track for its biggest one-day gain since April 19, 2023, when it rose 10.9%, and has gained for four of the last five days.The company said late Tuesday it expects fourth-quarter revenue of around $1.93 billion, up 17% and above FactSet forecasts for $1 ...

Key TakeawaysU.S. equities were up at midday on Wednesday, Jan. 10, 2024 ahead of key inflation data and earnings reports due later in the week.Intuitive Surgical's preliminary results were better than expected, and shares advanced.American Express shares fell after a downgrade by BMO Capital Markets on banking industry headwinds.U.S. equities were up at midday ahead of key inflation data and earnings reports due later in the week. The Dow, S&P 500, and Nasdaq were all in the green.Intuitive Surgical (ISRG) ...

Key TakeawaysIntuitive Surgical's preliminary fourth-quarter results were above analysts' estimates as the number of procedures using its surgical devices increased.The company said demand for procedures rose as China lifted its COVID-19 restrictions.Full-year total procedures were up on a jump in cancer surgeries.Shares of Intuitive Surgical (ISRG) moved sharply higher Wednesday as the maker of the da Vinci robotic surgical device said it anticipates better-than-expected results on a rise in surgical proce ...

Shares of Intuitive Surgical Inc. ISRG, +0.52% rallied after hours on Tuesday after the maker of robotic surgical equipment said it expected fourth-quarter sales that were above Wall Street’s expectations, helped by a recovery in China. The company reported preliminary fourth-quarter revenue of around $1.93 billion, up 17% and above FactSet forecasts for $1.87 billion. Procedures involving da Vinci, its robotic surgical system, jumped 21% from a year earlier, when COVID-19 cases re-emerged in China and wei ...

Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $328.86, moving +1.97% from the previous trading session. The stock's change was more than the S&P 500's daily gain of 1.41%. On the other hand, the Dow registered a gain of 0.58%, and the technology-centric Nasdaq increased by 2.2%.Shares of the company have appreciated by 3.89% over the course of the past month, underperforming the Medical sector's gain of 6.57% and outperforming the S&P 500's gain of 2.9%.Investors will be eagerly watc ...